MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jendso/bvag112

Медицинская библиотека · Journal of the Endocrine Society · 2026

Clinical burden of classic congenital adrenal hyperplasia and glucocorticoid-related complications: a claims analysis.

Kim Hyunwoo, Lin Vivian H, Newfield Ron S, Dauber Andrew, Luo Michelle, Cicero Samantha, Li Michael, Zhao Cecilia, Cheng Henry Kim

СтатьяПеревод в очереди

Аннотация

CONTEXT: Classic congenital adrenal hyperplasia (CAH) is a rare genetic condition characterized by impaired cortisol and aldosterone synthesis. Historical management required glucocorticoid (GC) therapy to replace cortisol and, often, to suppress excess ACTH and adrenal androgens. However, supraphysiologic GC doses can lead to substantial complications.

OBJECTIVE

This study aimed to characterize the clinical burden associated with CAH and quantify the degree to which CAH- and/or GC-related complications manifest.

METHODS

Retrospective cohort analyses were conducted using administrative claims data from MarketScan® Research Databases (1/1/2020-12/31/2022) to quantify the burden of CAH- and/or GC-related complications among insured patients with CAH in the United States compared with a matched cohort.

RESULTS

A total of 719 patients with CAH receiving GC therapy were matched 1:5 with 3595 individuals based on age, sex, payer, region, and enrollment duration. Patients with CAH had significantly higher rates of predominantly GC-related complications, including cardiovascular/circulatory diseases, type 2 diabetes, hypertension, hyperglycemia, metabolic complications, obesity, and osteoporosis (all P < .05). Patients with CAH demonstrated significantly higher rates and risks of nearly all CAH-related complications compared with matched controls (P < .05). Rates and risks of nearly all complications categorized as both CAH- and GC-related were significantly higher among patients with CAH (P < .05). Rates were consistently higher in adults than pediatric patients, underscoring the progressive and cumulative nature of CAH- and GC-related morbidity.

CONCLUSION

Individuals with CAH experience higher rates and risks of CAH- and/or GC-related complications, highlighting the considerable burden associated with CAH and supraphysiologic GC treatment. Higher complication rates in adults emphasize the need for early and effective management of CAH. Novel non-GC therapies may enable GC dose reduction while maintaining androgen control, potentially mitigating these complications.

Для цитирования: Kim Hyunwoo, Lin Vivian H, Newfield Ron S, Dauber Andrew, Luo Michelle, Cicero Samantha, Li Michael, Zhao Cecilia, Cheng Henry Kim. Clinical burden of classic congenital adrenal hyperplasia and glucocorticoid-related complications: a claims analysis.. Journal of the Endocrine Society. 2026. DOI: 10.1210/jendso/bvag112.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.